European marketing application for semuloparin withdrawn

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1414, 2012-01, pp. : 4-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An additional Japanese marketing application for ubenimex [Bestatin] has been withdrawn

By  

Inpharma, Vol. 1, Iss. 1428, 2004-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

Additional data is required by European regulatory authorities considering IDM Pharma's marketing authorisation application for mifamurtide

By  

Inpharma, Vol. 1, Iss. 1646, 2008-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Co-proxamol to be withdrawn in the UK

By  

Reactions Weekly, Vol. 1, Iss. 1037, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Cisapride to be withdrawn in Canada

By  

Inpharma, Vol. 1, Iss. 1243, 2000-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Cerivastatin withdrawn in the UK and the US

By  

Inpharma, Vol. 1, Iss. 1301, 2001-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite